Page last updated: 2024-08-23

sufentanil and Hepatocellular Carcinoma

sufentanil has been researched along with Hepatocellular Carcinoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Feng, ZY; Gao, YP; Guo, JG; Guo, XJ; Lu, XY; Rao, YF; Sun, JH; Zhao, LP; Zhou, TY	1

Other Studies

1 other study(ies) available for sufentanil and Hepatocellular Carcinoma

Article	Year
Novel multimodal analgesia regimen improves post-TACE pain in patients with hepatocellular carcinoma. Hepatobiliary & pancreatic diseases international : HBPD INT, 2018, Volume: 17, Issue:6 Topics: Adult; Aged; Analgesia, Patient-Controlled; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cost-Benefit Analysis; Female; Health Care Costs; Humans; Isoxazoles; Liver Neoplasms; Male; Middle Aged; Pain, Postoperative; Patient Satisfaction; Postoperative Nausea and Vomiting; Sufentanil	2018

Article

Year

Novel multimodal analgesia regimen improves post-TACE pain in patients with hepatocellular carcinoma.

Hepatobiliary & pancreatic diseases international : HBPD INT, 2018, Volume: 17, Issue:6

Topics: Adult; Aged; Analgesia, Patient-Controlled; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cost-Benefit Analysis; Female; Health Care Costs; Humans; Isoxazoles; Liver Neoplasms; Male; Middle Aged; Pain, Postoperative; Patient Satisfaction; Postoperative Nausea and Vomiting; Sufentanil

2018